| Mosunetuzumab and Zeprumetostat in Treating Patients With Follicular Lymphoma (NCT07555470) | Institute of Hematology & Blood Diseases Hospital, China | 2026-04-10 |
| A Study of Ivonescimab, Chemotherapy, and Stereotactic Radiosurgery for People With Non-Small Cell Lung Cancer (NCT07535463) | Memorial Sloan Kettering Cancer Center | 2026-04-10 |
| Efficacy and Safety of Low-dose Bevacizumab Plus Adebrelimab Combined With Transarterial Chemoembolization Followed by Hepatic Arterial Infusion Chemotherapy (TACE-HAIC) as First-line Treatment for Unresectable Hepatocellular Carcinoma: A Single-arm Phase 2 Trial (NCT07543783) | Third Affiliated Hospital, Sun Yat-Sen University | 2026-04-10 |
| Stereotactic Body Radiotherapy Plus FAK and RAF/MEK Inhibition in Advanced Pancreatic Adenocarcinoma (NCT07126158) | Washington University School of Medicine | 2026-04-10 |
| Tolecizumab Plus Chemoimmunotherapy for pMMR/MSS Locally Advanced Colon Adenocarcinoma (NCT07468630) | Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | 2026-04-10 |
| Evaluate the Efficacy and Safety of GZR101-80 Injection in Patients With Type 2 Diabetes (NCT07387003) | Gan & Lee Pharmaceuticals. | 2026-04-10 |
| Pharmacokinetic and Early Efficacy of OPT101 in Patients With Type 1 Diabetes Mellitus (NCT06964087) | Op-T LLC | 2026-04-10 |
| MT2025-35 Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced Intensity Conditioning Treosulfan and Fludarabine, With Post-Transplant Cytoxan (PTCy) for the Treatment of Hematological Diseases (NCT07493538) | Masonic Cancer Center, University of Minnesota | 2026-04-10 |
| Intravesical GEM/DOCE for HR BCG-Unresponsive NMIBC (NCT07322263) | Michael A. O'Donnell | 2026-04-10 |
| Reduced-dose Carboplatin-doublet-chemotherapy + Cemiplimab vs Cemiplimab Monotherapy in Treatment Naive Older and Frail Patients With Metastatic NSCLC With PD-L1 <50% (NCT07020065) | Swiss Cancer Institute | 2026-04-10 |
| An Extension of SKY-0515 in Participants With Huntington's Disease (NCT07537075) | Skyhawk Therapeutics, Inc. | 2026-04-10 |
| ASCERV Study: MRG003 Combined With QL1706 in Recurrent or Metastatic Cervical Cancer (NCT07542717) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2026-04-10 |
| Efficacy and Safety of Butylphthalide in the Treatment of Multiple System Atrophy (NCT07518810) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2026-04-10 |
| Yittrium-90(Y-90) Fibroblast Activation Protein Inhibitor (FAPI) Therapy in Patients With Non-Small Cell Lung Cancer (Phase II) (NCT07500285) | Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization | 2026-04-10 |
| Antegrade Intestinal Fluid Reinfusion for Prevention of Low Anterior Resection Syndrome After Low Anterior Resection: a Single-Center, Prospective Randomized Controlled Trial. (NCT07537998) | Pei-Rong Ding | 2026-04-10 |
| Neoadjuvant Chemotherapy, Anti-PD-1 Antibody and Sitagliptin for Locally Advanced pMMR CRC (NCT07365592) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2026-04-09 |
| A Phase II Study Evaluating BMS-986504 in MTAP-deleted Pancreatic Cancer (NCT07283705) | M.D. Anderson Cancer Center | 2026-04-09 |
| Bronchial Artery Chemoembolization (BACE) Combination Therapy for Advanced NSCLC (NCT07738367) | Fujian Cancer Hospital | 2026-04-09 |
| A Study of CP-COV03 Compared With Placebo in Participants With Dengue (Part 1) and Dengue-like Illness (Part 2) (NCT07576868) | Hyundai Bioscience Co., Ltd. | 2026-04-09 |
| A Study of Ivonescimab in Combination With Dato-DXd or Osimertinib in People With Non-Small Cell Lung Cancer (NCT07535437) | Memorial Sloan Kettering Cancer Center | 2026-04-09 |
| A Clinical Study of SHR-4394 in Combination With Anti-tumor Therapy in Prostate Cancer (NCT07407283) | Jiangsu HengRui Medicine Co., Ltd. | 2026-04-08 |
| Targeting the Pathophysiology of Sickle Cell-Related Kidney Disease Using the SGLT2 Inhibitors, Empagliflozin (NCT07175051) | University of Illinois at Chicago | 2026-04-08 |
| MRG006A Combination Therapy for Advanced Hepatocellular Carcinoma (Phase I/II) (NCT07479485) | Lepu Biopharma Co., Ltd. | 2026-04-08 |
| A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M) (NCT07519395) | GlaxoSmithKline | 2026-04-08 |
| Intravesical Aminophylline for Urgent Ureteral Stenting in Acute Calculous Anuria (NCT07617948) | Beni-Suef University | 2026-04-08 |
| Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatment in Stage IIIB-IV Non-small Cell Lung Cancer, IMMUNO-BIOMAP Trial (NCT07288034) | City of Hope Medical Center | 2026-04-08 |
| A Study of SKB518 as Monotherapy or Combination Therapy in Patients With Advanced Gynecological Malignant Tumors (NCT07448922) | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | 2026-04-08 |
| A Study to Evaluate the Safety, Efficacy, and Pharmacodynamics of PLL001 in ALS Patients (NCT06513546) | PLL TX AUSTRALIA PTY LTD | 2026-04-08 |
| Recombinant Glycosylated Human Interleukin-7 (CYT107) for the Treatment of Kaposi Sarcoma in Participants With HIV and Immune Non-Response (REGIMENKS HIV) (NCT07308886) | National Cancer Institute (NCI) | 2026-04-08 |
| Study of the Relaxin Agonist R2R01 in Patients at High Risk for Cardiac Surgery Associated- Acute Kidney Injury (NCT07625553) | River 2 Renal Corp. | 2026-04-07 |
| BCMA-CD19 cCAR T for the Treatment of Refractory Inflammatory Bowel Disease (IBD) (NCT07544160) | iCell Gene Therapeutics | 2026-04-07 |
| Zanidatamab Before Surgery for the Treatment of HER2 Positive Colon and Rectal Cancer in Patients Planned for Curative Intent Treatment (NCT07405476) | Emory University | 2026-04-07 |
| Comparison of Anticoagulant Effects of Different Doses of Nafamostat in Continuous Renal Replacement Therapy (CRRT) in the Intensive Care Unit (ICU) (NCT07469072) | Zhujiang Hospital | 2026-04-07 |
| A Study to Estimate Early Clinical Efficacy Signals of GLP-1 Agonist Administration in Conjunction With Levonorgestrel Intrauterine Device in Obese Patients With Endometrioid Intraepithelial Neoplasia (NCT07107334) | University of Florida | 2026-04-07 |
| Sleep and Stress Study (NCT07315516) | RDC Clinical Pty Ltd | 2026-04-07 |
| A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus Ribociclib Plus Fulvestrant in Participants With Advanced Breast Cancer (NCT07405801) | Hoffmann-La Roche | 2026-04-07 |
| Radiopharmaceutical Treatment of Advanced Kidney Cancer (NCT06783348) | European Organisation for Research and Treatment of Cancer - EORTC | 2026-04-07 |
| A Study to Evaluate the Efficacy and Safety of AK139 in Patients With Moderate-to-severe Atopic Dermatitis (NCT07502222) | Akeso | 2026-04-07 |
| HUMSCs Combined With Col I to Third-Degree Burn Wound (NCT07530003) | The First Affiliated Hospital of Xinxiang Medical College | 2026-04-06 |
| Collaborative Clinical-translational Cohort of Amivantamab Plus Lazertinib and Amivantamab Plus Chemotherapy in Patients With EGFR-mutant, Locally Advanced or Metastatic/Recurrent Non-Small Cell Lung Cancer (INSTAR Study) (NCT07507188) | Yonsei University | 2026-04-06 |
| Safety and Tolerability Study of Human Neural Stem Cells for Huntington's Disease (NCT07451613) | Leslie Thompson | 2026-04-06 |
| Window of Opportunity in Preserving Laryngeal Function Trial (NCT07423078) | Matthew Spector | 2026-04-06 |
| DOC1021 Dendritic Cell Immunotherapy for Refractory Melanoma (NCT07288112) | Diakonos Oncology Corporation | 2026-04-06 |
| Efficacy and Safety of Oral KAI-7535 in Adult Participants Living With Obesity or Overweight With at Least 1 Weight-Related Comorbidity (NCT07497880) | Kailera | 2026-04-06 |
| Nab-Paclitaxel Combined With Local Therapy in Relapsed SCLC (NCT07547332) | Shanghai Pulmonary Hospital, Shanghai, China | 2026-04-06 |
| Comparison of the Pharmacokinetics (PK) and Pharmacodynamics (PD) Biosimilarity of Proposed Biosimilar/Interchangeable Rapid-Acting Insulin Aspart (I004) and NovoLog® After Single-Dose Subcutaneous Administration to Healthy Volunteers (NCT07560150) | Amphastar Pharmaceuticals, Inc. | 2026-04-06 |
| Proteinuria in Normotensive Diabetic Patients: ARBs Alone or in Combination of SGLT2i (NCT07586371) | Dr Mudassar Saeed Pansota | 2026-04-06 |
| Neoadjuvant Therapy With Iparomlimab and Tuvonralimab, Lenvatinib and Chemotherapy in Resectable ESCC (NCT07490002) | Changhai Hospital | 2026-04-06 |
| Exploratory Clinical Study on the Safety and Efficacy of CD19X CAR-T Cell Injection in the Treatment of Relapsed/Refractory Large B-Cell Lymphoma (NCT07447726) | Institute of Hematology & Blood Diseases Hospital, China | 2026-04-05 |
| Neoadjuvant Therapy for Early Triple-Negative Breast Cancer: A Response-Guided Approach Using Iparomlimab and Tuvonralimab Injection in Combination With Chemotherapy (NCT07372079) | Tianjin Medical University Cancer Institute and Hospital | 2026-04-05 |
| Botulinum Toxin in the Palatopharyngeal Muscle for the Treatment of Obstructive Sleep Apnea (NCT07399782) | Hospital Felicio Rocho | 2026-04-05 |
| A Phase II Study of QLS12010 Capsules in Adults With Moderate to Severe Atopic Dermatitis (NCT07344051) | Qilu Pharmaceutical Co., Ltd. | 2026-04-05 |
| A Phase 2 Safety and Efficacy Study Evaluating CS-101 in Participants With β-Thalassemia Major (NCT07489196) | CorrectSequence Therapeutics Co., Ltd | 2026-04-05 |
| A Study of ASP2246 for People Who Have Movement Problems Caused by Brain Injury After a Stroke (NCT07318714) | Astellas Pharma Inc | 2026-04-03 |
| A Study of SHR-2173 in Participants With Systemic Lupus Erythematosus (NCT07299422) | Guangdong Hengrui Pharmaceutical Co., Ltd | 2026-04-03 |
| Sonlicromanol in Post-COVID (NCT07298005) | Michele van Vugt | 2026-04-03 |
| SHR-1701 With or Without Apatinib in Combination With Chemotherapy as Neoadjuvant Therapy for Gastric Cancer (NCT07464756) | The First Affiliated Hospital with Nanjing Medical University | 2026-04-03 |
| ALL Backbone in AYAs (NCT07227584) | Dana-Farber Cancer Institute | 2026-04-03 |
| Confirmatory Clinical Study in Active Ulcerative Colitis (NCT07296315) | MRM Health NV | 2026-04-03 |
| A Phase I/IIa Study of C5252 in Patients With Intracranial Tumor (NCT07243340) | ImmVira Pharma Co. Ltd | 2026-04-03 |
| Human Laboratory Study of Apremilast for Alcohol Use Disorder (NCT07325266) | National Institute on Alcohol Abuse and Alcoholism (NIAAA) | 2026-04-03 |
| A Phase II Clinical Study of SKB571 as Monotherapy in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer With MET Abnormalities (NCT07308106) | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | 2026-04-03 |
| TCM Formula vs. HMB in Pre-Frail Elders: Muscle Strength and Bone Status (NCT07597850) | Tri-Service General Hospital (TSGH) | 2026-04-02 |
| TUDCA in High-Risk Lactating Mothers Identified by Early Postpartum Milk Hydrophobicity Index (NCT07517276) | Peking University First Hospital | 2026-04-02 |
| A Clinical Trial of EHT102 Injection in Pediatric Patients With Biallelic hOTOF Mutations (NCT07288580) | Shanghai Euhearing Therapeutics Co., Ltd | 2026-04-02 |
| A Study of CS060380 Tablets in Patients With MASH and Obesity (NCT07466017) | Cascade Pharmaceuticals, Inc | 2026-04-02 |
| Trial Assessing Fianlimab Plus Cemiplimab Plus Chemotherapy or Cemiplimab Plus Chemotherapy in Patients With Pleural Mesothelioma (NCT07234058) | Intergroupe Francophone de Cancerologie Thoracique | 2026-04-02 |
| Y-90 Radioembolization, Durvalumab, Tremelimumab, and Zanzalintinib for the Treatment of Unresectable and Locally-Advanced Hepatocellular Carcinoma (NCT07511504) | OHSU Knight Cancer Institute | 2026-04-02 |
| Evaluating NALIRIFOX vs Modified Gemcitabine, Nab-Paclitaxel and Cisplatin in Patients With Locally Advanced and Metastatic Pancreatic Adenocarcinoma (NCT07076212) | Medical University of South Carolina | 2026-04-02 |
| Clinical Trials of Benmelstobart Injection Combined With Anlotinib Hydrochloride Capsules in the Treatment of Advanced or Unresectable Alveolar Soft Part Sarcoma (NCT07548177) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2026-04-02 |
| Cannabidiol for the Treatment of Diabetic Peripheral Neuropathy: Pilot Study (NCT07298408) | Florida A&M University | 2026-04-02 |
| MAG-PAIN - MAGnesium for Postoperative Analgesia In the Newly Delivered (NCT07528612) | Region Halland | 2026-04-02 |
| Evaluating the Impact of GLP-1 Receptor Agonists With Total Neoadjuvant Therapy in Rectal Cancer (NCT07314528) | St. James's Hospital, Ireland | 2026-04-01 |
| A Randomized, Double-Blind, Placebo Controlled Study to Assess the Efficacy and Safety of SNP-610 for the Treatment of Patients With Non-alcoholic Steatohepatitis (NCT03468556) | Sinew Pharma Inc. | 2026-04-01 |
| SKB264 Plus Glecirasib in Advanced KRAS G12C-Mutant NSCLC: A Phase II Study (NCT07670013) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2026-04-01 |
| Combination of Mitoxantrone Liposome and Etoposide, Dexamethasone, Pegaspargase and Golidocitinib (MEPL-G) in the Treatment of NK/T-cell Lymphoma Associated Hemophagocytic Lymphohistiocytosis (NKTCL-HLH) (NCT07525466) | Beijing Tongren Hospital | 2026-04-01 |
| QLS12010 Capsules in Adults With Moderate to Severe Hidradenitis Suppurativa (NCT07417917) | Qilu Pharmaceutical Co., Ltd. | 2026-04-01 |
| Comparing Efficacy and Safety of (Meropenem + Colistin) Versus (Imipenem/Cilastatin + Tigecycline) on Eradication of Multi-Drug Resistance Bacteria (NCT07524920) | Ain Shams University | 2026-04-01 |
| Neoadjuvant Becotatug Vedotin Plus Pucotenlimab in Locally Advanced Oral and Oropharyngeal Squamous Cell Carcinoma (OSCC) (NCT07545083) | Shanghai Zhongshan Hospital | 2026-04-01 |
| Lenvatinib or Regorafenib for Advanced Hepatocellular Carcinoma After Immunotherapy (REVIVE) (NCT07495579) | Asan Medical Center | 2026-04-01 |
| Tocilizumab in Chronic Inflammatory CPPD Disease (NCT07254637) | Assistance Publique - Hôpitaux de Paris | 2026-04-01 |
| Tunlametinib in Combination With Pucotenlimab and Hydroxychloroquine in NRAS Mutant Melanoma (NCT07750067) | Sun Yat-sen University | 2026-04-01 |
| Iparomlimab and Tuvonralimab Injection Combined With SBRT in Patients With Early-Stage Non-Small Cell Lung Cancer (NCT07379398) | Tianjin Medical University Cancer Institute and Hospital | 2026-04-01 |
| A Phase 2/3 Study on the Efficacy and Safety of Mangaciclanol for Contrast-Enhanced MRI of CNS or Body in Adult Patients (NCT07472491) | GE Healthcare | 2026-04-01 |
| Sacituzumab Tirumotecan in Combination With Anlotinib in Previously Treated Patients With Extensive-Stage Small Cell Lung Cancer (ES-SCLC) (NCT07501169) | Sichuan University | 2026-04-01 |
| A Study of IBI3003 in Subjects With Relapsed or Refractory Multiple Myeloma (NCT07336472) | Fortvita Biologics (USA)Inc. | 2026-04-01 |
| Omitting Nasogastric Tube Decompression in Minimally Invasive Pancreaticoduodenectomy (NCT07370116) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2026-04-01 |
| KALM-B: Ketamine-assisted Psychotherapy (KAP) to Lessen Morbidity After Burn Injury (NCT07563296) | Irma Fleming | 2026-04-01 |
| A Clinical Trial Evaluating the Efficacy and Safety of HSK55718 in Patients for Postoperative Pain Treatment in Orthopedic Surgery (NCT07551739) | Haisco Pharmaceutical Group Co., Ltd. | 2026-04-01 |
| Caffeine for Infants Born at 28 to 34 Weeks Receiving Respiratory Support (NCT07456670) | Queen's University | 2026-04-01 |
| Biolosion Combined Standard Neoadjuvant Therapy to Treat Triple-negative Breast Cancer (NCT06768931) | Sun Yat-sen University | 2026-04-01 |
| Biologics in Folliculitis Decalvans : an Adaptative Trial Research (NCT07268534) | Assistance Publique - Hôpitaux de Paris | 2026-04-01 |
| Combination of High and Low-Dose Radiotherapy With Immune Therapy and TKI in Advanced Colorectal Cancer: A Phase II Study (NCT07467590) | Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | 2026-04-01 |
| Personalized Antisense Oligonucleotide for A Single Participant With PACS1 Gene Mutation Associated With Schuurs-Hoeijmakers Syndrome (SHMS) (NCT07474298) | n-Lorem Foundation | 2026-04-01 |
| Long-term Follow-up Study of Patients Who Received EG110A, a Non-replicative Herpes Simplex Virus 1-derived Gene Therapy (NCT07227285) | Cyllene Therapeutics | 2026-04-01 |
| Phase II Interventional Study Evaluating Efficacy and Safety of Secukinumab in Active Severe Takayasu Patients (NCT07477795) | Assistance Publique - Hôpitaux de Paris | 2026-04-01 |
| A Single-arm, Prospective, Phase II Clinical Study of the Combination of Entinostat and Oral Paclitaxel in the Treatment of HR+HER2- Advanced Breast Cancer (NCT07441486) | Tianjin Medical University Cancer Institute and Hospital | 2026-04-01 |
| A Phase Ib/II Study Evaluating Injectable ALK-N001 in Patients With Advanced Solid Tumors (NCT07509684) | Zhejiang Anglikang Pharmaceutical Co., Ltd. | 2026-04-01 |
| A Phase 2, Baseline-Controlled Study Evaluating the Safety and Efficacy of PTX-022 (Sirolimus) Topical Gel 3.9% in the Treatment of Angiokeratomas (LOTU) (NCT07552077) | Palvella Therapeutics, Inc. | 2026-04-01 |
| Psilocybin AsSisted pSychotherapy for the treatmENt of Gambling disordER : a Pilot Study (NCT07391332) | Nantes University Hospital | 2026-04-01 |